Siemens Diagnostics’ Sales Activities for NGAL Suspended Until Further  
1/17/2013 9:14:54 AM

BioPorto has received notification from Siemens Diagnostics of a communication to their international subsidiaries putting a halt to sales activities concerning The NGAL TestTM. Siemens will refer interested customers to BioPorto. BioPorto is now looking further into the reasons for this and the prospects for activities being resumed.